Tetsuya Kamataki

633 total citations
11 papers, 530 citations indexed

About

Tetsuya Kamataki is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Tetsuya Kamataki has authored 11 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Tetsuya Kamataki's work include Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (3 papers) and Cancer therapeutics and mechanisms (2 papers). Tetsuya Kamataki is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (3 papers) and Cancer therapeutics and mechanisms (2 papers). Tetsuya Kamataki collaborates with scholars based in Japan, United States and Sweden. Tetsuya Kamataki's co-authors include Susumu Itoh, Ryuji Kitamura, Hisashi Hashimoto, Masako Fujita, Eiichi Nagai, Takehiro Hagiwara, Masaaki Hirohashi, Kiyoshi Takasuna, Mamoru Nomura and Dieter Müller‐Enoch and has published in prestigious journals such as European Journal of Biochemistry, Archives of Biochemistry and Biophysics and Carcinogenesis.

In The Last Decade

Tetsuya Kamataki

11 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuya Kamataki Japan	8	285	267	242	72	54	11	530
Hiromitsu Nakasa Japan	13	333 1.2×	210 0.8×	137 0.6×	67 0.9×	60 1.1×	30	596
Charlotta Otter Sweden	12	659 2.3×	391 1.5×	274 1.1×	71 1.0×	95 1.8×	16	893
Srinivasa Rao Jada Singapore	11	165 0.6×	306 1.1×	238 1.0×	42 0.6×	27 0.5×	18	652
R H Tukey United States	7	324 1.1×	136 0.5×	255 1.1×	30 0.4×	55 1.0×	9	635
H. Yoshitsugu Japan	5	243 0.9×	161 0.6×	141 0.6×	40 0.6×	28 0.5×	6	518
Harriet Gullstén Finland	8	517 1.8×	200 0.7×	327 1.4×	23 0.3×	69 1.3×	9	774
Jos Van Houdt Belgium	10	346 1.2×	189 0.7×	140 0.6×	33 0.5×	21 0.4×	15	515
M.D. Green United States	11	244 0.9×	127 0.5×	147 0.6×	29 0.4×	24 0.4×	12	431
Antony J. Hansen Australia	12	288 1.0×	175 0.7×	266 1.1×	49 0.7×	75 1.4×	13	537
Marià Pitarque Spain	10	255 0.9×	109 0.4×	260 1.1×	19 0.3×	58 1.1×	12	731

Countries citing papers authored by Tetsuya Kamataki

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Kamataki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Kamataki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Kamataki more than expected).

Fields of papers citing papers by Tetsuya Kamataki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Kamataki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Kamataki. The network helps show where Tetsuya Kamataki may publish in the future.

Co-authorship network of co-authors of Tetsuya Kamataki

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Kamataki. A scholar is included among the top collaborators of Tetsuya Kamataki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Kamataki. Tetsuya Kamataki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Takasuna, Kiyoshi, Takehiro Hagiwara, Masaaki Hirohashi, et al.. (1998). Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats. Cancer Chemotherapy and Pharmacology. 42(4). 280–286. 91 indexed citations

Mori, Toshiyuki, Susumu Itoh, & Tetsuya Kamataki. (1998). Molecular cloning and regulation of a novel guinea pig cytochrome P450 (CYP3A20) which differs from guinea pig CYP3A14 in only two amino acid residues. IUBMB Life. 44(6). 1245–1253. 1 indexed citations

Li, Yong, Tsuyoshi Yokoi, Ryuji Kitamura, et al.. (1996). Establishment of Transgenic Mice Carrying Human Fetus-Specific CYP3A7. Archives of Biochemistry and Biophysics. 329(2). 235–240. 33 indexed citations

Takasuna, Kiyoshi, Yoshio Kasai, Yutaka Kitano, et al.. (1995). Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats. Japanese Journal of Cancer Research. 86(10). 978–984. 85 indexed citations

Kitamura, Ryuji, et al.. (1993). Increased CYP1A2 content and capacity to activate Glu-P-1 and Trp-P-2 in liver microsomes of scorbutic ODS rats. Carcinogenesis. 14(12). 2471–2475. 7 indexed citations

Hashimoto, Hisashi, et al.. (1993). Gene structure of CYP3A4, an adult‐specific form of cytochrome P450 in human livers, and its transcriptional control. European Journal of Biochemistry. 218(2). 585–595. 179 indexed citations

Itoh, Susumu, et al.. (1992). Genomic organization of human fetal specific P-450IIIA7(cytochrome P-450HFLa)-related gene(s) and interaction of transcriptional regulatory factor with its DNA element in the 5′ flanking region. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1130(2). 133–138. 40 indexed citations

Itoh, Susumu, et al.. (1992). Mouse liver cytochrome P-450 (P-450IIIAm1): its cDNA cloning and inducibility by dexamethasone. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1130(3). 329–332. 64 indexed citations

Nakura, Hironori, Hiroaki Ohi, Toshiaki Miura, et al.. (1991). Formation of an Antibacterial Metabolite from a New Macrolide Compound 23-O-Benzyl-5-mycaminosyl-tylonolide (TMC-101), by a Hepatic Microsomal Drug-Metabolizing Enzyme System.. Journal of Pharmacobio-Dynamics. 14(7). 377–383. 1 indexed citations

10.

Fujioka, Yasunori, Kazuo Nagashima, Takanori Hashizume, et al.. (1989). Distributional variation of P-450 immunoreactive hepatocytes in human liver disorders. Human Pathology. 20(10). 1015–1020. 7 indexed citations

11.

Kitada, Mitsukazu, Tetsuya Kamataki, K. Itahashi, et al.. (1988). Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics. Archives of Biochemistry and Biophysics. 264(1). 61–66. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact